GlassScriptPhysician profile
Landon Hall
NPI 1194171272
$11,251.25
in general payments reported to CMS, 2019-2025
10 companies · $3,715 in 2025
The $3,715 reported for 2025 was more than what 79% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,175 · 2021: $941 · 2022: $1,902 · 2023: $498 · 2024: $19.97 · 2025: $3,715.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,847 · Food and Beverage: $1,133 · Education: $254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,846.84 |
| Food and Beverage | $1,132.62 |
| Education | $253.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $4,174.69 | 2019 | |
| Stryker Corporation | $3,357.87 | 2021-2025 | Mako |
| Zimmer Biomet Holdings, INC. | $2,045.23 | 2022-2023 | Persona |
| Depuy Synthes Sales INC. | $1,308.78 | 2022-2025 | Attune |
| Smith+Nephew, INC. | $113.82 | 2021 | |
| Medical Device Business Services, INC. | $112.52 | 2025 | Attune |
| Onkos Surgical, INC. | $89.28 | 2025 | Eleos Limb Salvage System |
| Amgen INC. | $19.97 | 2024 | Prolia, Evenity |
| Ferring Pharmaceuticals INC. | $14.96 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $14.13 | 2023 | Exparel, Iovera, Zilretta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Landon Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.